 | • レポートコード：MRC2-11QY09104 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は未熟児網膜症治療のグローバル市場について調査・分析したレポートです。種類別（IB-09A0133、メカセルミンリンファベート、プロプラノロール、R-200、その他）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別未熟児網膜症治療の競争状況、市場シェア ・世界の未熟児網膜症治療市場：種類別市場規模 2015年-2020年（IB-09A0133、メカセルミンリンファベート、プロプラノロール、R-200、その他） ・世界の未熟児網膜症治療市場：種類別市場規模予測 2021年-2026年（IB-09A0133、メカセルミンリンファベート、プロプラノロール、R-200、その他） ・世界の未熟児網膜症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅ケア） ・世界の未熟児網膜症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅ケア） ・北米の未熟児網膜症治療市場分析：米国、カナダ ・ヨーロッパの未熟児網膜症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの未熟児網膜症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の未熟児網膜症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの未熟児網膜症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biomar Microbial Technologies、D. Western Therapeutics Institute Inc、F. Hoffmann-La Roche Ltd、Insmed Inc、Recordati SpA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Retinopathy Of Prematurity Therapeutics Market
The global Retinopathy Of Prematurity Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Retinopathy Of Prematurity Therapeutics Scope and Market Size
Retinopathy Of Prematurity Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinopathy Of Prematurity Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Retinopathy Of Prematurity Therapeutics market is segmented into
IB-09A0133
Mecasermin Rinfabate
Propranolol
R-200
Others
Segment by Application, the Retinopathy Of Prematurity Therapeutics market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Retinopathy Of Prematurity Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Retinopathy Of Prematurity Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Retinopathy Of Prematurity Therapeutics Market Share Analysis
Retinopathy Of Prematurity Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Retinopathy Of Prematurity Therapeutics business, the date to enter into the Retinopathy Of Prematurity Therapeutics market, Retinopathy Of Prematurity Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Biomar Microbial Technologies
D. Western Therapeutics Institute Inc
F. Hoffmann-La Roche Ltd
Insmed Inc
Recordati SpA
…
1 Study Coverage
1.1 Retinopathy Of Prematurity Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Retinopathy Of Prematurity Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type
1.4.2 IB-09A0133
1.4.3 Mecasermin Rinfabate
1.4.4 Propranolol
1.4.5 R-200
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Retinopathy Of Prematurity Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Retinopathy Of Prematurity Therapeutics Revenue 2015-2026
2.1.2 Global Retinopathy Of Prematurity Therapeutics Sales 2015-2026
2.2 Global Retinopathy Of Prematurity Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Retinopathy Of Prematurity Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Retinopathy Of Prematurity Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Retinopathy Of Prematurity Therapeutics Competitor Landscape by Players
3.1 Retinopathy Of Prematurity Therapeutics Sales by Manufacturers
3.1.1 Retinopathy Of Prematurity Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Retinopathy Of Prematurity Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Retinopathy Of Prematurity Therapeutics Revenue by Manufacturers
3.2.1 Retinopathy Of Prematurity Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Retinopathy Of Prematurity Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Retinopathy Of Prematurity Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Retinopathy Of Prematurity Therapeutics Revenue in 2019
3.2.5 Global Retinopathy Of Prematurity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Retinopathy Of Prematurity Therapeutics Price by Manufacturers
3.4 Retinopathy Of Prematurity Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Retinopathy Of Prematurity Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Retinopathy Of Prematurity Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Retinopathy Of Prematurity Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retinopathy Of Prematurity Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020)
4.1.2 Global Retinopathy Of Prematurity Therapeutics Revenue by Type (2015-2020)
4.1.3 Retinopathy Of Prematurity Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Retinopathy Of Prematurity Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Retinopathy Of Prematurity Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Retinopathy Of Prematurity Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Retinopathy Of Prematurity Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Retinopathy Of Prematurity Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Retinopathy Of Prematurity Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020)
5.1.2 Global Retinopathy Of Prematurity Therapeutics Revenue by Application (2015-2020)
5.1.3 Retinopathy Of Prematurity Therapeutics Price by Application (2015-2020)
5.2 Retinopathy Of Prematurity Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Retinopathy Of Prematurity Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Retinopathy Of Prematurity Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Retinopathy Of Prematurity Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Retinopathy Of Prematurity Therapeutics by Country
6.1.1 North America Retinopathy Of Prematurity Therapeutics Sales by Country
6.1.2 North America Retinopathy Of Prematurity Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Type
6.3 North America Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Retinopathy Of Prematurity Therapeutics by Country
7.1.1 Europe Retinopathy Of Prematurity Therapeutics Sales by Country
7.1.2 Europe Retinopathy Of Prematurity Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Type
7.3 Europe Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Retinopathy Of Prematurity Therapeutics by Region
8.1.1 Asia Pacific Retinopathy Of Prematurity Therapeutics Sales by Region
8.1.2 Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Retinopathy Of Prematurity Therapeutics by Country
9.1.1 Latin America Retinopathy Of Prematurity Therapeutics Sales by Country
9.1.2 Latin America Retinopathy Of Prematurity Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Type
9.3 Central & South America Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Retinopathy Of Prematurity Therapeutics by Country
10.1.1 Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales by Country
10.1.2 Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Retinopathy Of Prematurity Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Biomar Microbial Technologies
11.1.1 Biomar Microbial Technologies Corporation Information
11.1.2 Biomar Microbial Technologies Description and Business Overview
11.1.3 Biomar Microbial Technologies Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Products Offered
11.1.5 Biomar Microbial Technologies Related Developments
11.2 D. Western Therapeutics Institute Inc
11.2.1 D. Western Therapeutics Institute Inc Corporation Information
11.2.2 D. Western Therapeutics Institute Inc Description and Business Overview
11.2.3 D. Western Therapeutics Institute Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Products Offered
11.2.5 D. Western Therapeutics Institute Inc Related Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Products Offered
11.3.5 F. Hoffmann-La Roche Ltd Related Developments
11.4 Insmed Inc
11.4.1 Insmed Inc Corporation Information
11.4.2 Insmed Inc Description and Business Overview
11.4.3 Insmed Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Insmed Inc Retinopathy Of Prematurity Therapeutics Products Offered
11.4.5 Insmed Inc Related Developments
11.5 Recordati SpA
11.5.1 Recordati SpA Corporation Information
11.5.2 Recordati SpA Description and Business Overview
11.5.3 Recordati SpA Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Recordati SpA Retinopathy Of Prematurity Therapeutics Products Offered
11.5.5 Recordati SpA Related Developments
11.1 Biomar Microbial Technologies
11.1.1 Biomar Microbial Technologies Corporation Information
11.1.2 Biomar Microbial Technologies Description and Business Overview
11.1.3 Biomar Microbial Technologies Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Products Offered
11.1.5 Biomar Microbial Technologies Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Retinopathy Of Prematurity Therapeutics Market Estimates and Projections by Region
12.1.1 Global Retinopathy Of Prematurity Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Retinopathy Of Prematurity Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Retinopathy Of Prematurity Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Retinopathy Of Prematurity Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Retinopathy Of Prematurity Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Retinopathy Of Prematurity Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Retinopathy Of Prematurity Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Retinopathy Of Prematurity Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Retinopathy Of Prematurity Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Retinopathy Of Prematurity Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Retinopathy Of Prematurity Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Retinopathy Of Prematurity Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Retinopathy Of Prematurity Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Retinopathy Of Prematurity Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Retinopathy Of Prematurity Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Retinopathy Of Prematurity Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Retinopathy Of Prematurity Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Retinopathy Of Prematurity Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Retinopathy Of Prematurity Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Retinopathy Of Prematurity Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Retinopathy Of Prematurity Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Retinopathy Of Prematurity Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Retinopathy Of Prematurity Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Retinopathy Of Prematurity Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Retinopathy Of Prematurity Therapeutics Market Segments
Table 2. Ranking of Global Top Retinopathy Of Prematurity Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of IB-09A0133
Table 5. Major Manufacturers of Mecasermin Rinfabate
Table 6. Major Manufacturers of Propranolol
Table 7. Major Manufacturers of R-200
Table 8. Major Manufacturers of Others
Table 9. Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Retinopathy Of Prematurity Therapeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Retinopathy Of Prematurity Therapeutics Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Regions (2015-2020)
Table 13. Global Retinopathy Of Prematurity Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Retinopathy Of Prematurity Therapeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Retinopathy Of Prematurity Therapeutics Sales Share by Manufacturers (2015-2020)
Table 16. Global Retinopathy Of Prematurity Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Retinopathy Of Prematurity Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinopathy Of Prematurity Therapeutics as of 2019)
Table 18. Retinopathy Of Prematurity Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Retinopathy Of Prematurity Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Retinopathy Of Prematurity Therapeutics Price (2015-2020) (USD/Pcs)
Table 21. Retinopathy Of Prematurity Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Retinopathy Of Prematurity Therapeutics Product Type
Table 23. Date of International Manufacturers Enter into Retinopathy Of Prematurity Therapeutics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 26. Global Retinopathy Of Prematurity Therapeutics Sales Share by Type (2015-2020)
Table 27. Global Retinopathy Of Prematurity Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Retinopathy Of Prematurity Therapeutics Revenue Share by Type (2015-2020)
Table 29. Retinopathy Of Prematurity Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 31. Global Retinopathy Of Prematurity Therapeutics Sales Share by Application (2015-2020)
Table 32. North America Retinopathy Of Prematurity Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 33. North America Retinopathy Of Prematurity Therapeutics Sales Market Share by Country (2015-2020)
Table 34. North America Retinopathy Of Prematurity Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country (2015-2020)
Table 36. North America Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 37. North America Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Table 38. North America Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 39. North America Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Table 40. Europe Retinopathy Of Prematurity Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Retinopathy Of Prematurity Therapeutics Sales Market Share by Country (2015-2020)
Table 42. Europe Retinopathy Of Prematurity Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country (2015-2020)
Table 44. Europe Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Table 46. Europe Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Table 56. Latin America Retinopathy Of Prematurity Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Retinopathy Of Prematurity Therapeutics Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Retinopathy Of Prematurity Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country (2015-2020)
Table 60. Latin America Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Table 62. Latin America Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Table 72. Biomar Microbial Technologies Corporation Information
Table 73. Biomar Microbial Technologies Description and Major Businesses
Table 74. Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Biomar Microbial Technologies Product
Table 76. Biomar Microbial Technologies Recent Development
Table 77. D. Western Therapeutics Institute Inc Corporation Information
Table 78. D. Western Therapeutics Institute Inc Description and Major Businesses
Table 79. D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. D. Western Therapeutics Institute Inc Product
Table 81. D. Western Therapeutics Institute Inc Recent Development
Table 82. F. Hoffmann-La Roche Ltd Corporation Information
Table 83. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 84. F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. F. Hoffmann-La Roche Ltd Product
Table 86. F. Hoffmann-La Roche Ltd Recent Development
Table 87. Insmed Inc Corporation Information
Table 88. Insmed Inc Description and Major Businesses
Table 89. Insmed Inc Retinopathy Of Prematurity Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Insmed Inc Product
Table 91. Insmed Inc Recent Development
Table 92. Recordati SpA Corporation Information
Table 93. Recordati SpA Description and Major Businesses
Table 94. Recordati SpA Retinopathy Of Prematurity Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Recordati SpA Product
Table 96. Recordati SpA Recent Development
Table 97. Global Retinopathy Of Prematurity Therapeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Retinopathy Of Prematurity Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Retinopathy Of Prematurity Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Retinopathy Of Prematurity Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Retinopathy Of Prematurity Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Retinopathy Of Prematurity Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Retinopathy Of Prematurity Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Retinopathy Of Prematurity Therapeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Retinopathy Of Prematurity Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Retinopathy Of Prematurity Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Retinopathy Of Prematurity Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Retinopathy Of Prematurity Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Retinopathy Of Prematurity Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Retinopathy Of Prematurity Therapeutics Players
Table 115. Retinopathy Of Prematurity Therapeutics Customers List
Table 116. Retinopathy Of Prematurity Therapeutics Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinopathy Of Prematurity Therapeutics Product Picture
Figure 2. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. IB-09A0133 Product Picture
Figure 4. Mecasermin Rinfabate Product Picture
Figure 5. Propranolol Product Picture
Figure 6. R-200 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Care
Figure 12. Retinopathy Of Prematurity Therapeutics Report Years Considered
Figure 13. Global Retinopathy Of Prematurity Therapeutics Market Size 2015-2026 (US$ Million)
Figure 14. Global Retinopathy Of Prematurity Therapeutics Sales 2015-2026 (K Pcs)
Figure 15. Global Retinopathy Of Prematurity Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Region (2015-2020)
Figure 17. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Region in 2019
Figure 18. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Region (2015-2020)
Figure 19. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Region in 2019
Figure 20. Global Retinopathy Of Prematurity Therapeutics Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Retinopathy Of Prematurity Therapeutics Revenue in 2019
Figure 22. Retinopathy Of Prematurity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Type (2015-2020)
Figure 24. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Type in 2019
Figure 25. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2015-2020)
Figure 26. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type in 2019
Figure 27. Global Retinopathy Of Prematurity Therapeutics Market Share by Price Range (2015-2020)
Figure 28. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Application (2015-2020)
Figure 29. Global Retinopathy Of Prematurity Therapeutics Sales Market Share by Application in 2019
Figure 30. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application (2015-2020)
Figure 31. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application in 2019
Figure 32. North America Retinopathy Of Prematurity Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Retinopathy Of Prematurity Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Retinopathy Of Prematurity Therapeutics Sales Market Share by Country in 2019
Figure 35. North America Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country in 2019
Figure 36. U.S. Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Retinopathy Of Prematurity Therapeutics Market Share by Type in 2019
Figure 41. North America Retinopathy Of Prematurity Therapeutics Market Share by Application in 2019
Figure 42. Europe Retinopathy Of Prematurity Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Retinopathy Of Prematurity Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Retinopathy Of Prematurity Therapeutics Sales Market Share by Country in 2019
Figure 45. Europe Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country in 2019
Figure 46. Germany Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Retinopathy Of Prematurity Therapeutics Market Share by Type in 2019
Figure 57. Europe Retinopathy Of Prematurity Therapeutics Market Share by Application in 2019
Figure 58. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Market Share by Region in 2019
Figure 61. Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue Market Share by Region in 2019
Figure 62. China Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Retinopathy Of Prematurity Therapeutics Market Share by Type in 2019
Figure 85. Asia Pacific Retinopathy Of Prematurity Therapeutics Market Share by Application in 2019
Figure 86. Latin America Retinopathy Of Prematurity Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Retinopathy Of Prematurity Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Retinopathy Of Prematurity Therapeutics Sales Market Share by Country in 2019
Figure 89. Latin America Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country in 2019
Figure 90. Mexico Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Type in 2019
Figure 97. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Application in 2019
Figure 98. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue Market Share by Country in 2019
Figure 102. Turkey Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Retinopathy Of Prematurity Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Retinopathy Of Prematurity Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Retinopathy Of Prematurity Therapeutics Market Share by Type in 2019
Figure 109. Middle East and Africa Retinopathy Of Prematurity Therapeutics Market Share by Application in 2019
Figure 110. North America Retinopathy Of Prematurity Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Retinopathy Of Prematurity Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Retinopathy Of Prematurity Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Retinopathy Of Prematurity Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Retinopathy Of Prematurity Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Retinopathy Of Prematurity Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Retinopathy Of Prematurity Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Retinopathy Of Prematurity Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Retinopathy Of Prematurity Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Retinopathy Of Prematurity Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
増殖性糖尿病性網膜症治療治療薬の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proliferative Diabe…- 糖尿病網膜症（DR）の世界市場（～2026年） Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…
- 糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 増殖性糖尿病性網膜症の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Market The global Proliferative Diabetic Retinopathy market size is projected to reach US$ 455.6 million by 2026, from US$ 430.5 million in 2020, at a CAGR of 5.4%% during 2021-2026. Global Proliferative Diabetic Retinopathy Sco…